Product Categories
| Country: | China |
|---|---|
| Tel: | 0573-0573-88133976-8014 |
| Mobile: | 18868399006 |
| E-mail: | rd007@hg-pharma.com |
| QQ: | 3628549417 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 3-Ethoxy-4-methoxybenzamide | C10H13NO3 | 247569-89-7 | Details |
| 1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanol | C12H18O5S | 2055542-18-0 | Details |
| N-[(1-Methyl-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-β-alanine ethyl ester | C19H20N4O3 | 1702936-92-2 | Details |
| Hexyl N-[(4-aminophenyl)iminomethyl]carbamate | C14H21N3O2 | 255706-13-9 | Details |
| 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-phenyl-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one | C23H22F6N4O3 | 170729-76-7 | Details |
| 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine | C12H17NO4S | 1450657-31-4 | Details |
| (R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE | C8H14N2O2 | 103765-01-1 | Details |
| LevetiracetaM IMpurity B | C8H12N2O2 | 358629-47-7 | Details |
| Deoxybenzoin Oxime | C14H13NO | 952-06-7 | Details |
| 2,5-Difluoropyridine | C5H3F2N | 84476-99-3 | Details |
| Parecoxib Impurity H | C22H23N3O7S2 | 1708094-99-8 | Details |
| (S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide | C8H15ClN2O2 | 102767-31-7 | Details |
| 1-(4-Ethoxyphenyl)-4,5,6,7-tetrahydro-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C26H27N5O4 | 1928718-22-2 | Details |
| N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine ethyl ester | C34H40N6O6 | 1408238-40-3 | Details |
| N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine | C32H36N6O6 | 1408238-37-8 | Details |
| (R)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine | C12H19NO4S | 608142-27-4 | Details |
| 1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl) ethanone | C12H16O5S | 1450657-28-9 | Details |
| Valdecoxib IMpurity B | C32H25N3O6S2 | 1373038-60-8 | Details |
| Deoxybenzoin Oxime | C14H13NO | 26306-06-9 | Details |
| Parecoxib Impurity 4 | C14H13NO | 57736-10-4 | Details |
| N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine methyl ester | C33H39N7O5 | 211915-00-3 | Details |
| (Z)-ethyl 3-(2-(((4-(N'-((2-ethylbutoxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C33H39N7O5 | 2096992-10-6 | Details |
| Ethyl 2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylate | C26H33N5O4 | 1408238-36-7 | Details |
| Parecoxib ImpurityO | C20H20N2O4S | 198470-91-6 | Details |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide | C20H20N2O4S | 198470-82-5 | Details |
| 1-(4-Chlorophenyl)-4,5,6,7-tetrahydro-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C10H17N3OS | 1246818-51-8 | Details |
| (6R)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine | C10H17N3S | 104632-28-2 | Details |
| ENT-Aprepitant | C23H21F7N4O3 | 172822-29-6 | Details |
| (6S,7S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)-7-benzothiazolol | C10H17N3OS | 1001648-71-0 | Details |
| ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate 4-methylbenzenesulfonate | C33H35N7O6S | 1610758-16-1 | Details |
| Pregabalin Impurity 19 | C11H14O3 | 89015-27-0 | Details |
| Pregabalin EP Impurity A | C8H15NO | 181289-23-6 | Details |
| Valdecoxib Impurity D (Parecoxib Impurity 8) | C16H13NO4S | 181696-35-5 | Details |
| VALDECOXIB | C16H14N2O3S | 181695-72-7 | Details |
| Parecoxib Sodium Impurity 14 | C19H18N2O4S | 1709956-89-7 | Details |
| (3R)-3-(Aminomethyl)-5-methylhexanoic acid | C8H17NO2 | 148553-51-9 | Details |
| Nα-(2,4-Dinitro-5-fluorophenyl)-L-alaninamide | C9H9FN4O5 | 95713-52-3 | Details |
| 3-Isobutylglutarimid | C9H15NO2 | 916982-10-0 | Details |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide | C18H16N2O4S | 198471-06-6 | Details |
| 3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide | C16H14N2O3S | 386273-25-2 | Details |
| Apixaban IMpurity 3 (BMS-778960-01) | C25H25N5O4 | 1801881-18-4 | Details |
| Apixaban Impurity 2 | C25H25N5O4 | 1801881-16-2 | Details |
| Apixaban Impurity 23 | C24H23N5O3 | 1801881-17-3 | Details |
| N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine | C32H37N7O5 | 212321-78-3 | Details |
| 3-(5-methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide | C16H15N3O5S2 | 1373038-59-5 | Details |
| 5-methyl-3,4-diphenyl-4,5-dihydroisoxazol-5-ol | C16H15NO2 | 181696-73-1 | Details |
| ((2R,3R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate | Details |
| ((2R,3R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate | Details |
| ((2R,3R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate | Details |
| 1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | C9H10F2N2O5 | 114248-23-6 | Details |
| ((2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate | C16H15F2N3O5 | Details |
| (2R,3R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate | C23H19F2N3O6 | 134790-40-2 | Details |
| (2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid | C8H13NO3 | 102849-49-0 | Details |
| 1-((2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | C9H10F2N2O5 | 153381-14-7 | Details |
| 4-amino-1-((2S,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrochloride | C9H12ClF2N3O4 | Details |
| 4,4'-(sulfonylbis(4,1-phenylene))bis(5-methyl-3-phenylisoxazole) | C32H24N2O4S | 2338845-31-9 | Details |
| Apixaban Impurity BMS-591329 | C24H22ClN5O3 | 2029205-64-7 | Details |
| 4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]morpholine | C14H22BN3O3 | 1186041-99-5 | Details |
| 2(5H)-Furanone,4-phenyl- | C10H8O2 | 1575-47-9 | Details |
| 2(5H)-Furanone, 5-hydroxy-4-phenyl- | C10H8O3 | 78920-11-3 | Details |
| C7H6ClN3 | 57892-71-4 | Details |
| C13H21N3O2 | 1315478-13-7 | Details |
| 5-Pyrimidineacetamide, 1-([1,1'-biphenyl]-4-ylmethyl)-2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo- | C26H31N3O2 | 1985668-79-8 | Details |
| 4-(2-chloro-5-nitrobenzyl)morpholine | C11H13ClN2O3 | 952490-82-3 | Details |
| C7H13ClN2O2 | 110971-82-9 | Details |
| C9H9BrO2 | 3042-81-7 | Details |
| dihydro-4-phenylfuran-2(3H)-one | C10H10O2 | 1008-73-7 | Details |
| C10H12O3 | 3558-61-0 | Details |
| C26H31N3OS | 1985668-75-4 | Details |
| C9H7NO | 874379-35-8 | Details |
| 3-(2-aminoethyl)thiazolidine-2,4-dione hydrochloride | C5H9ClN2O2S | 19382-49-1 | Details |
| Benzoic acid, 5-bromo-2-[[(1,1-dimethylethoxy)carbonyl]amino]- (9CI) | C12H14BrNO4 | 306937-20-2 | Details |
| 2-IODO-3-METHYLBENZONITRILE | C8H6IN | 52107-70-7 | Details |
| 3-hydroxy-N-methylpyridine-2-carboxamide | C7H8N2O2 | 1196-30-1 | Details |
| Sodium 3-bromopyridine-2-sulfinate | C5H5BrNNaO2S | 2137725-62-1 | Details |
| Sodium 3-chloropyridine-2-sulfinate | C5H4ClNO2S.Na | 2733902-40-2 | Details |
| 1-(4-Trifluoromethylpyrimidin-2-yl)piperazine | C9H11F3N4 | 179756-91-3 | Details |
| (5-methoxypyridin-2-yl)methanol | C7H9NO2 | 127978-70-5 | Details |
| 4,5-Dimethoxybenzene-1,2-diamine dihydrochloride | C8H14Cl2N2O2 | 131076-14-7 | Details |
| 6-Iodo-7-methoxyquinazolin-4(3H)-one | C9H7IN2O2 | 206190-25-2 | Details |
| 5-fluoro-2-hydrazinopyridine dihydrochloride | C5H8Cl2FN3 | 1401426-18-3 | Details |
| 7-methoxyimidazo[1,2-a]pyridine-2-carboxylic acid | C9H8N2O3 | 129912-15-8 | Details |
| 1-(Benzylamino)propan-2-ol | C10H15NO | 27159-32-6 | Details |
| 3-(1-Hydroxyethyl)benzoic acid | C9H10O3 | 283608-37-7 | Details |
| 2-Methyltetrahydro-2H-pyran-4-ol | C6H12O2 | 89791-47-9 | Details |
| sodium 3-aminobenzenesulfonate | C6H6NNaO3S | 1126-34-7 | Details |
| [2-(1H-Pyrrol-1-yl)ethyl]amine | C6H10N2 | 29709-35-1 | Details |
| 1-((Tetrahydrofuran-2-yl)methyl)piperazine | C9H18N2O | 82500-35-4 | Details |
| (2-Vinylphenyl)methanol | C9H10O | 35106-82-2 | Details |
| 4,6-Dichloro-2-(pyridin-2-yl)pyrimidine | C9H5Cl2N3 | 10235-65-1 | Details |
| benzyl 3-amino-4-oxopiperidine-1-carboxylate hydrochloride | C13H17ClN2O3 | 1196145-01-3 | Details |
| 2-Amino-5-bromo-3-methylpyrazine | C5H6BrN3 | 74290-67-8 | Details |
| 3-Chloro-4-isopropoxycyclobut-3-ene-1,2-dione | C7H7ClO3 | 130837-47-7 | Details |
| 2-(1H-Benzo[d][1,2,3]triazol-1-yl)-2-(((benzyloxy)carbonyl)amino)acetic acid | C16H14N4O4 | 124676-19-3 | Details |
| 2-(hexahydro-1H-pyrrolizin-7a-yl)acetic acid hydrochloride | C9H16ClNO2 | 124655-63-6 | Details |
| (S)-2-Aminobutyramide hydrochloride | C4H11ClN2O | 7682-20-4 | Details |
| 4-(6-Chloropyrazin-2-yl)morpholine | C8H10ClN3O | 720693-19-6 | Details |
| N-Nitroso Benazepril | Details |
| Sodium 4-hydroxy-3-phenylbutanoate | C10H13NaO3 | 40951-19-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||